Bondarzewia dickinsii Against Colitis-Associated Cancer Through the Suppression of the PI3K/AKT/COX-2 Pathway and Inhibition of PGE2 Production in Mice
Nutrients · 2024
DOI: 10.3390/nu16234048 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Junliang Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Engineering Research Center of Edible and Medicinal Fungi, Ministry of Education, Jilin Agricultural University, Changchun 130118, China. Hauptthemen laut MEDLINE: Dinoprostone, Cyclooxygenase 2, Proto-Oncogene Proteins c-akt, Mice, Inbred C57BL. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Jilin Province, Tianjin Synthetic Biotechnology Innovation Capacity Improvement Project, the earmarked fund for CARS-20 (Edible Mushroom).
Abstract (Originalsprache)
Background
Bondarzewia dickinsii (BD) is a newly discovered edible mushroom with rich nutritional components. This study presents a thorough analysis of the components of BD, examining its inhibitory effects and the underlying mechanisms by which BD influences colitis-associated cancer (CAC).
Methods
AOM/DSS-induced CAC mice (male C57BL/6) were used, and a histopathological analysis, intestinal microbiota assessment, and metabolomics profiling were carried out, as well as an evaluation of relevant proteins and factors, to investigate the CAC-inhibitory effects of BD.
Results
BD is rich in nutritional components, including a total sugar content of 37.29% and total protein content of 24.9%. BD significantly diminished colon inflammation, as well as the size and quantity of tumors. In addition, BD modified the diversity of intestinal microbiota and changed the levels of 19 serum metabolites, including arachidonic acid. BD significantly reduced prostaglandin E2 (PGE2) and cyclooxygenase-2 (COX-2) in colon tissue. Furthermore, it was found to inhibit the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT)/COX-2 signaling pathway.
Conclusions
In general, BD inhibited the onset and progression of CAC by modulating the composition of intestinal microbiota and metabolite levels, suppressing the PI3K/AKT/COX-2 pathway, and decreasing PGE2 expression. This study provides a significant reference for the development of BD as a dietary supplement and pharmaceutical agent in the treatment of CAC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Engineering Research Center of Edible and Medicinal Fungi, Ministry of Education, Jilin Agricultural University, Changchun 130118, China.
- Science and Research Center for Edible Fungi of Qingyuan County, Qingyuan 323800, China.
- Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin 300308, China.
- National Center of Technology Innovation for Synthetic Biology, Tianjin 300308, China.
- Science Popularization Service Center of Jilin Province, Changchun 130021, China.
Förderung
- Natural Science Foundation of Jilin Province
- Tianjin Synthetic Biotechnology Innovation Capacity Improvement Project
- the earmarked fund for CARS-20 (Edible Mushroom)
Zitieren
APA
Chen, J., Liu, S., Zhang, X., Dai, X., Li, Y., Han, Y., & Li, L. (2024). Bondarzewia dickinsii Against Colitis-Associated Cancer Through the Suppression of the PI3K/AKT/COX-2 Pathway and Inhibition of PGE2 Production in Mice. Nutrients. https://doi.org/10.3390/nu16234048
Vancouver
Chen J, Liu S, Zhang X, Dai X, Li Y, Han Y, et al. Bondarzewia dickinsii Against Colitis-Associated Cancer Through the Suppression of the PI3K/AKT/COX-2 Pathway and Inhibition of PGE2 Production in Mice. Nutrients. 2024. doi:10.3390/nu16234048
BibTeX
@article{Chen2024,
author = {Chen, Junliang and Liu, Shuai and Zhang, Xin and Dai, Xiaojing and Li, Yu and Han, Yonglin and Li, Lanzhou},
title = {Bondarzewia dickinsii Against Colitis-Associated Cancer Through the Suppression of the PI3K/AKT/COX-2 Pathway and Inhibition of PGE2 Production in Mice},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16234048}
}
EUVIMED